Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Kyowa Kirin Co., Ltd. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
KYKOY
Over the counter
2830
www.kyowakirin.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Kyowa Kirin Co., Ltd.
Kura Oncology and Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial and Positive FDA Feedback for Upcoming Frontline Combination Trial Designs
- Feb 5th, 2025 9:01 pm
Kura Oncology and Kyowa Kirin Report Positive Combination Data for Ziftomenib at American Society of Hematology Annual Meeting
- Dec 9th, 2024 12:00 pm
Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias
- Nov 20th, 2024 10:00 pm
Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company
- Oct 31st, 2024 6:40 am
Kyowa Kirin Announces Top-line Data from Rocatinlimab Phase 3 ROCKET HORIZON Trial for Adults with Moderate to Severe Atopic Dermatitis
- Sep 25th, 2024 11:00 am
Kyowa Kirin to Present New Research Spotlighting Global Efforts to Advance Science and Patient Care in X-linked Hypophosphatemia at ASBMR Annual Meeting
- Sep 19th, 2024 12:00 pm
New Analysis Demonstrates Impaired Work Productivity and Increased Unemployment Rates in Adults with X-linked Hypophosphatemia (XLH)
- Sep 10th, 2024 12:00 pm
Kyowa Kirin to end distribution of Fareston (toremefine) in the United States
- Aug 23rd, 2024 3:05 pm
Kyowa Kirin Announces a New Sustainable Business Strategy for the Asia-Pacific (APAC) Region
- Aug 1st, 2024 6:45 am
Kyowa Kirin Announces Board Approval for Construction of New Biologics Manufacturing Plant in Sanford, NC
- Jun 10th, 2024 11:30 am
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and Ophthalmology Annual Meeting 2024
- May 8th, 2024 9:30 pm
First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome
- Apr 15th, 2024 1:15 pm
Kyowa Kirin Announces Acceptance of Abstract for Presentation at the Association for Research in Vision and Ophthalmology Annual Meeting 2024
- Apr 2nd, 2024 5:15 pm
Kyowa Kirin Will Present Phase 2b Post-hoc Analysis and Symposium at the American Academy of Dermatology Annual Meeting 2024
- Mar 8th, 2024 3:00 pm
Kyowa Kirin Announce Symposium, Acceptance of Abstract for Presentation at American Academy of Dermatology 2024 Meeting
- Feb 14th, 2024 12:00 pm
Scroll